ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Oridonin suppresses gastric cancer SGC-7901 cell proliferation by targeting the TNF-alpha/androgen receptor/TGF-beta signalling pathway axis

Gao, Shiyong*; Tan, Huixin*; Li, Dan哈尔滨商业大学; 哈尔滨医科大学
Journal of Cellular and Molecular Medicine2023-7-11DOI: 10.1111/jcmm.17841
4被引7阅读
引用收藏
分享

摘要

Statistics provided by GLOBOCAN list gastric cancer as the sixth most common, with a mortality ranking of third highest for the year 2020. In China, a herb called Rabdosia rubescens (Hemsl.) H. Hara, has been used by local residents for the treatment of digestive tract cancer for hundreds of years. Oridonin, the main ingredient of the herb, has a curative effect for gastric cancer, but the mechanism has not been previously clarified. This study mainly aimed to investigate the role of TNF--alpha/Androgen receptor/TGF--beta signalling pathway axis in mediating the proliferation inhibition of oridonin on gastric cancer SGC--7901 cells. MTT assay, cell morphology observation assay and fluorescence assay were adopted to study the efficacy of oridonin on cell proliferation. The network pharmacology was used to predict the pathway axis regulated by oridonin. Western blot assay was adopted to verify the TNF-gamma/Androgen receptor/TGF-ss signalling pathway axis regulation on gastric cancer by oridonin. The results showed Oridonin could inhibit the proliferation of gastric cancer cells, change cell morphology and cause cell nuclear fragmentation. A total of 11signaling pathways were annotated by the network pharmacology, among them, Tumour necrosis factor alpha ( TNF-alpha) signalling pathway, androgen receptor (AR) signalling pathway and transforming growth factor ( TGF-ss) signalling pathway account for the largest proportion. Oridonin can regulate the protein expression of the three signalling pathways, which is consistent with the results predicted by network pharmacology. These findings indicated that oridonin can inhibit the proliferation of gastric cancer SGC-7901 cells by regulating the TNF-alpha /AR /TGF-ss signalling pathway axis.

学科与关键词

关键词
AR signalling pathwaygastric canceroridoninTGF-beta signalling pathwayTNF-gamma signalling pathway
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Journal of Cellular and Molecular Medicine
发表日期
2023-07-11
DOI
10.1111/jcmm.17841
语言
ENGLISH
成果收录
SCIE
资助标注
Natural Science Foundation in Heilongjiang Province [LH2021H002]; 2021 Harbin University of Commerce Teacher "Innovation" Project [LH2021H002]; Outstanding Young Talents Project of the Central Government's Fund for Local Universities' Reform and Development [2020YQ12]; Science and Technology Project of Heilongjiang Provincial Health and Family Planning Commission [2017132]; General Project of Education Department of Heilongjiang Province [12541571]

作者

  • G

    Gao, Shiyong (通讯) (第一作者)

    harbin univ commerce

  • T

    Tan, Huixin (通讯)

    harbin med univ

查看全部 3 位作者收起作者
  • L

    Li, Dan

    harbin univ commerce

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417